Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - venlafaxine as hydrochloride - capsules extended release - venlafaxine as hydrochloride 150 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

Israel - English - Ministry of Health

dexcel ltd, israel - venlafaxine as hydrochloride - tablets - venlafaxine as hydrochloride 37.5 mg - venlafaxine - venlafaxine - for the treatment of depression.

Israel - English - Ministry of Health

perrigo israel agencies ltd - milnacipran hydrochloride - capsules - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

Israel - English - Ministry of Health

perrigo israel agencies ltd - milnacipran hydrochloride - capsules - milnacipran hydrochloride 50.0 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

Israel - English - Ministry of Health

bayer israel ltd - ethinylestradiol; levonorgestrel - coated tablets - levonorgestrel 150 mcg; ethinylestradiol 30 mcg - progestogens and estrogens, fixed combinations - oral contraceptive.

Israel - English - Ministry of Health

rafa laboratories ltd - hyperici herba extractum siccum - film coated tablets - hyperici herba extractum siccum 250 mg - other antidepressants - symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions. treatment is recommended for up to 24 weeks.

Israel - English - Ministry of Health

rafa laboratories ltd - hyperici herba extractum siccum - film coated tablets - hyperici herba extractum siccum 500 mg - other antidepressants - symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions.treatment is recommended for up to 24 weeks.

Israel - English - Ministry of Health

bayer israel ltd - hypericum perforatum - film coated tablets - hypericum perforatum 612 mg - symptoms of mild to moderate depression. treatment is recommended for up to 24 weeks.

European Union - English - EMA (European Medicines Agency)

clinuvel europe limited - afamelanotide - protoporphyria, erythropoietic - emollients and protectives - prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp).

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - escitalopram oxalate, quantity: 25.548 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; maize starch; magnesium stearate; mannitol; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000 - treatment of major depression. ,treatment of social anxiety disorder (social phobia). ,treatment of generalised anxiety disorder. ,treatment of obsessive-compulsive disorder.